• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为泰国房颤患者选择华法林剂量的最佳策略

Optimal Strategies to Select Warfarin Dose for Thai Patients with Atrial Fibrillation.

作者信息

Ujjin Anunya, Wongcharoen Wanwarang, Suwanagool Arisara, Chai-Adisaksopha Chatree

机构信息

Division of Medicine, Neurological Institute of Thailand, Bangkok 10400, Thailand.

Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 52000, Thailand.

出版信息

J Clin Med. 2024 May 2;13(9):2675. doi: 10.3390/jcm13092675.

DOI:10.3390/jcm13092675
PMID:38731209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11084839/
Abstract

: Warfarin has been the mainstay treatment for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation (AF). The optimal starting dose of warfarin remains unclear. : To investigate the most optimal dosing strategies for warfarin starting dose in Thai patients with AF. : We enrolled consecutive AF patients who were starting on warfarin and resulting in a stable INR of 2.0-3.0 at two consecutive time points. We measured the dose of warfarin at which INR achieved the target range. The optimal dosage was defined as the difference from the actual dose within 20%. We compared strategies of warfarin dosing, including warfarin dosing formula, 2.5 mg, 3 mg and 5 mg doses. The primary endpoints were the proportions of patients in optimal, underdosing, and overdosing categories. : Among 1207 patients visiting the Outpatient Clinic between October 2011 and September 2021, 531 patients were identified with AF and INR in the therapeutic range of 2.0-3.0 on at least two consecutive visits. The mean age of participants was 68 ± 11 years, and men accounted for 44.4% of the population. The warfarin dosing formula resulted in optimal dosing in 37% and overdosing in 24% of cases, whereas the 2.5 mg, 3 mg and 5 mg doses resulted in optimal dosing in 36%, 39%, and 11%, and overdosing in 33%, 44% and 88% of patients, respectively ( < 0.01). : In Thai patients with AF, the optimal warfarin starting dose may be 2.5 mg, 3 mg or a simplified warfarin dosing formula, whereas the 5 mg dose should be avoided due to the high risk of overdosing.

摘要

华法林一直是预防心房颤动(AF)患者中风和全身性血栓栓塞的主要治疗药物。华法林的最佳起始剂量仍不明确。

目的

研究泰国AF患者华法林起始剂量的最优化给药策略。

方法

我们纳入了连续使用华法林且在两个连续时间点国际标准化比值(INR)稳定在2.0 - 3.0的AF患者。我们测量了INR达到目标范围时的华法林剂量。最佳剂量定义为与实际剂量相差在20%以内。我们比较了华法林给药策略,包括华法林给药公式、2.5毫克、3毫克和5毫克剂量。主要终点是处于最佳剂量、剂量不足和剂量过量类别的患者比例。

结果

在2011年10月至2021年9月期间到门诊就诊的1207例患者中,531例患者被确诊为AF且至少连续两次就诊时INR在2.0 - 3.0的治疗范围内。参与者的平均年龄为68±11岁,男性占人群的44.4%。华法林给药公式在37%的病例中导致最佳剂量,在24%的病例中导致剂量过量,而2.5毫克、3毫克和5毫克剂量分别在36%、39%和11%的患者中导致最佳剂量,在33%、44%和88%的患者中导致剂量过量(P<0.01)。

结论

在泰国AF患者中,华法林的最佳起始剂量可能是2.5毫克、3毫克或简化的华法林给药公式,而5毫克剂量因剂量过量风险高应避免使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4a/11084839/390994bec015/jcm-13-02675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4a/11084839/67f4927232a8/jcm-13-02675-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4a/11084839/bcc010a935aa/jcm-13-02675-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4a/11084839/30df63f4f727/jcm-13-02675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4a/11084839/390994bec015/jcm-13-02675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4a/11084839/67f4927232a8/jcm-13-02675-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4a/11084839/bcc010a935aa/jcm-13-02675-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4a/11084839/30df63f4f727/jcm-13-02675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b4a/11084839/390994bec015/jcm-13-02675-g002.jpg

相似文献

1
Optimal Strategies to Select Warfarin Dose for Thai Patients with Atrial Fibrillation.为泰国房颤患者选择华法林剂量的最佳策略
J Clin Med. 2024 May 2;13(9):2675. doi: 10.3390/jcm13092675.
2
Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies.比较利伐沙班治疗亚洲和非亚洲房颤患者时的标签内剂量、标签外低剂量和标签外高剂量的有效性和安全性:一项观察性研究的系统评价和荟萃分析。
Europace. 2023 Oct 5;25(10). doi: 10.1093/europace/euad288.
3
Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation.亚洲房颤患者非维生素K拮抗剂口服抗凝药的超说明书用药剂量与临床结局
Heart Rhythm. 2020 Dec;17(12):2102-2110. doi: 10.1016/j.hrthm.2020.07.022. Epub 2020 Jul 20.
4
Optimal INR level in Thai atrial fibrillation patients who were receiving warfarin for stroke prevention in Thailand.在泰国接受华法林预防卒中的心房颤动患者中的最佳国际标准化比值(INR)水平。
J Med Assoc Thai. 2014 Dec;97(12):1274-80.
5
Prevention of stroke in patients with atrial fibrillation.心房颤动患者的卒中预防
Semin Vasc Med. 2005 Aug;5(3):285-92. doi: 10.1055/s-2005-916168.
6
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.调整剂量华法林与低强度固定剂量华法林加阿司匹林用于高危房颤患者:房颤卒中预防III随机临床试验
Lancet. 1996 Sep 7;348(9028):633-8.
7
Warfarin Dosing According to the Genotype-guided Algorithm is Most Beneficial in Patients With Atrial Fibrillation: A Randomized Parallel Group Trial.根据基因型指导算法调整华法林剂量对房颤患者最为有益:一项随机平行组试验
Ther Drug Monit. 2018 Jun;40(3):362-368. doi: 10.1097/FTD.0000000000000501.
8
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.在 Outcomes Registry for Better Informed Treatment of Atrial Fibrillation 中,华法林控制指标与心房颤动结局的关系。
JAMA Cardiol. 2019 Aug 1;4(8):756-764. doi: 10.1001/jamacardio.2019.1960.
9
The efficacy of 3-mg warfarin initiating dose in adult Thai patients, who required long-term anticoagulant therapy.3毫克华法林起始剂量对需要长期抗凝治疗的泰国成年患者的疗效。
J Med Assoc Thai. 2011 Feb;94 Suppl 1:S225-31.
10
A Simple Formula for Predicting the Maintenance Dose of Warfarin with Reference to the Initial Response to Low Dosing at an Outpatient Clinic.一种参考门诊低剂量初始反应预测华法林维持剂量的简单公式。
Intern Med. 2020 Jan 1;59(1):29-35. doi: 10.2169/internalmedicine.3415-19. Epub 2019 Sep 11.

引用本文的文献

1
First-Ever Stroke Outcomes in Patients with Atrial Fibrillation: A Retrospective Cross-Sectional Study.心房颤动患者首次卒中的结局:一项回顾性横断面研究。
Medicines (Basel). 2025 Jul 24;12(3):18. doi: 10.3390/medicines12030018.

本文引用的文献

1
Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy.接受或未接受抗凝治疗的慢性肾脏病房颤患者的风险概况及治疗模式
TH Open. 2024 Feb 23;8(1):e106-e113. doi: 10.1055/s-0044-1780529. eCollection 2024 Jan.
2
Comparison of primary and secondary stroke prevention in patients with nonvalvular atrial fibrillation: Results from the RAFFINE registry.非瓣膜性心房颤动患者一级和二级卒中预防的比较:来自 RAFFINE 登记研究的结果。
J Stroke Cerebrovasc Dis. 2022 Dec;31(12):106871. doi: 10.1016/j.jstrokecerebrovasdis.2022.106871. Epub 2022 Nov 7.
3
Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020.
2011 年至 2020 年社区实践中 436864 例房颤患者口服抗凝剂使用趋势。
J Am Heart Assoc. 2022 Nov 15;11(22):e026723. doi: 10.1161/JAHA.122.026723. Epub 2022 Nov 8.
4
Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review.华法林剂量策略的演变及其在精准医学时代的进展:叙述性综述。
Int J Clin Pharm. 2022 Jun;44(3):599-607. doi: 10.1007/s11096-022-01386-8. Epub 2022 Mar 5.
5
Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.基因分型指导的华法林给药与非基因分型指导的华法林给药策略的疗效和安全性:27项随机对照试验的系统评价和荟萃分析。
Thromb Res. 2022 Feb;210:42-52. doi: 10.1016/j.thromres.2021.12.023. Epub 2021 Dec 25.
6
Selecting the right anticoagulant for stroke prevention in atrial fibrillation.选择合适的抗凝药物预防房颤相关性卒中。
Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4499-4505. doi: 10.26355/eurrev_202107_26241.
7
Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.基因指导的华法林在中国成年人中的剂量调整:一项多中心随机临床试验。
Circ Genom Precis Med. 2020 Aug;13(4):e002602. doi: 10.1161/CIRCGEN.119.002602. Epub 2020 Jun 8.
8
Atrial fibrillation-related stroke in women: Evidence and inequalities in epidemiology, mechanisms, clinical presentation, and management.女性心房颤动相关性卒中:流行病学、机制、临床表现和管理方面的证据和不平等。
Clin Cardiol. 2020 Jan;43(1):14-23. doi: 10.1002/clc.23284. Epub 2019 Nov 6.
9
A Simple Formula for Predicting the Maintenance Dose of Warfarin with Reference to the Initial Response to Low Dosing at an Outpatient Clinic.一种参考门诊低剂量初始反应预测华法林维持剂量的简单公式。
Intern Med. 2020 Jan 1;59(1):29-35. doi: 10.2169/internalmedicine.3415-19. Epub 2019 Sep 11.
10
Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.性别差异与心房颤动患者的卒中及主要不良临床事件:993600 例患者的系统评价和荟萃分析。
Int J Cardiol. 2018 Oct 15;269:182-191. doi: 10.1016/j.ijcard.2018.07.044. Epub 2018 Jul 9.